Raymond Schuch
17PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (17)
Sort by Publication Date:
|Feb 17, 2024
The Engineered Lysin CF-370 Is Active Against Antibiotic-Resistant Gram-Negative Pathogens In Vitro and Synergizes With Meropenem in Experimental Pseudomonas aeruginosa Pneumonia.Karen Sauve, Aubrey Watson, Jun T Oh
|Aug 10, 2023
Rapid bacteriolysis of Staphylococcus aureus by lysin exebacase.Xavier Vila-Farres, Karen Sauve, Jun Oh
|Mar 02, 2023
The Lysin Exebacase Has a Low Propensity for Resistance Development in Staphylococcus aureus and Suppresses the Emergence of Resistance to Antistaphylococcal Antibiotics.Jun Oh, Matthew Warner, Jane E Ambler
|Jul 21, 2022
Activity of Exebacase (CF-301) against Biofilms Formed by Staphylococcus epidermidis Strains Isolated from Prosthetic Joint Infections.Aubin Souche, Camille Kolenda, Jordan Teoli
|Sep 17, 2021
Correction for Oh et al., "Development of a Broth Microdilution Method for Exebacase Susceptibility Testing".Jun T Oh, Jane E Ambler, Cara Cassino
|Aug 16, 2021
Exebacase in Addition to Daptomycin against MRSA.Razieh Kebriaei, Kyle C Stamper, Katherine L Lev
Pageof 3
